524743 — Fischer Medical Ventures Income Statement
0.000.00%
- IN₹34.24bn
- IN₹34.24bn
- IN₹115.28m
Annual income statement for Fischer Medical Ventures, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 1.65 | 0 | 1.79 | 115 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | 8.05 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.07 | 1.83 | 1.89 | 1.64 | 117 |
Operating Profit | -2.07 | -0.176 | -1.89 | 0.152 | -1.96 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.41 | -0.356 | -1.97 | -0.013 | 5.39 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.41 | 1.41 | -2.33 | -0.365 | 4.03 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.41 | 1.41 | -2.33 | -0.365 | 4.03 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.41 | 1.41 | -2.33 | -0.365 | 4.03 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.39 | 8.18 | -13.5 | -2.12 | 0.36 |